Literature DB >> 8578310

Pseudotumor cerebri in systemic lupus erythematosus.

L Green1, S Vinker, H Amital, T Amir, Y Bar-Dayan, Y Levi, Y Schoenfeld.   

Abstract

OBJECTIVE: To assess the association between pseudotumor cerebri (PC) and systemic lupus erythematosus (SLE), and to seek a pathogenic mechanism that may elucidate the appearance of PC in patients with SLE. DATA SOURCE: Original English articles having the terms SLE, PC, or benign intracranial hypertension in their titles were identified by Medline search. In addition we report three new patients with this association. STUDY SYNTHESIS: Thirteen articles were found and 21 patients were analyzed. DATA EXTRACTION: Of the reported 21 patients, 18 were previously reported and 3 new patients with coexisting PC and SLE are described. The clinical characteristics of the patients is presented. Patients with PC and SLE generally had a more severe course of SLE; renal involvement occurred in 79%, massive proteinuria in 47%, and hematologic abnormalities were detected in a third. A hypercoagulable state manifest by either recurrent thromboembolic events or a high anti-cardiolipin antibody titer was detected in 58% of the patients described.
CONCLUSIONS: The association of PC and SLE is probably not coincidental. The high prevalence of serologic or clinical evidence of a hypercoagulable state suggests that microscopical thromboembolic events play a role in the genesis of PC.

Entities:  

Mesh:

Year:  1995        PMID: 8578310     DOI: 10.1016/s0049-0172(95)80023-9

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  11 in total

1.  Pseudotumour cerebri in lupus.

Authors:  Rashmi Roongta; Arghya Chattopadhyay; Shashwat Bhattacharyya; Alakendu Ghosh
Journal:  Clin Rheumatol       Date:  2020-11-10       Impact factor: 2.980

2.  [Neurological manifestations in connective tissue disease].

Authors:  L Harms; F Hiepe
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

3.  Benign intracranial hypertension associated to blood coagulation derangements.

Authors:  Domenico De Lucia; Marisanta Napolitano; Pierpaolo Di Micco; Alferio Niglio; Andrea Fontanella; Giuseppe Di lorio
Journal:  Thromb J       Date:  2006-12-24

4.  Papilloedema and Autoimmune Retinopathy from Systemic Lupus Erythematosus.

Authors:  John J Chen; Neeraj Kumar; Kathleen M McEvoy; Jacqueline A Leavitt
Journal:  Neuroophthalmology       Date:  2017-08-18

Review 5.  Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis.

Authors:  Roberto De Simone; Angelo Ranieri; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

6.  Idiopathic intracranial hypertension as the initial presentation of systemic lupus erythematosus.

Authors:  Chandrasekharan Rajasekharan; Sanu Watson Renjith; Ali Marzook; Rajasekharan Parvathy
Journal:  BMJ Case Rep       Date:  2013-01-31

7.  Idiopathic intracranial hypertension as an initial presentation of systemic lupus erythematosus.

Authors:  Keisha Maloney
Journal:  BMJ Case Rep       Date:  2013-08-13

8.  Intracranial hypertension: A rare presentation of lupus nephritis.

Authors:  Praveen Yadav; Anishkumar Nair; Ajith Cherian; N S Sibi; Ashwini Kumar
Journal:  J Pediatr Neurosci       Date:  2010-07

9.  Value of double - track sign in differentiating primary from thrombosed transverse sinus stenosis in patients presumed to have idiopathic intracranial hypertension.

Authors:  Nasser M Aldossary
Journal:  eNeurologicalSci       Date:  2018-01-16

10.  Spontaneous intracranial hypotension in a patient with systemic lupus erythematosus.

Authors:  Dan Isaac Cohen-Addad; Aslan Efendizade; Arkadij Grigorian; Kevin Hewitt; Vinodkumar Velayudhan
Journal:  Radiol Case Rep       Date:  2019-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.